new IV antibiotic for methicillin-resistant Staph aureus (MRSA) infections, Vibativ (vy-BA-tiv)
November 2009
Please see the June 2013 FDA release regarding the expanded use of Vibativ
It's the first in a new class. But it's related to vancomycin...and has many of vanco's drawbacks.
Vibativ (telavancin) is only approved for complicated skin and skin structure infections in adults. It covers gram-positive bacteria, including MRSA.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote